ClinicalTrials.Veeva

Menu

Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI

Mayo Clinic logo

Mayo Clinic

Status

Enrolling

Conditions

Spinal Cord Injuries

Treatments

Diagnostic Test: Tests of sympathetic inhibition
Diagnostic Test: Testing of below level sympathetic activation
Diagnostic Test: Tests of above level sympathetic activation

Study type

Interventional

Funder types

Other

Identifiers

NCT07210437
25-003333

Details and patient eligibility

About

The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.

Enrollment

18 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • 18-75 years old
  • Spinal cord injury with neurological level of injury from C6-T12
  • ASIA Impairment Scale A-D.
  • Either acute SCI <3 months prior (n=10) or chronic SCI (>1 year since injury, n=8).

Exclusion criteria

  • Symptoms of cardiovascular (including, but not limited to: hypertension, stroke, chest pain, etc.), respiratory, peripheral neurological or autonomic disease (particularly diabetes mellitus requiring treatment);
  • Women who are pregnant or lactating
  • Taking or being administered a medication known to potentially have adverse interactions with phenylephrine
  • In the judgement of the principal investigator, any illness or condition that will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of the study results.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

18 participants in 2 patient groups

Chronic Spinal Cord Injury
Experimental group
Treatment:
Diagnostic Test: Tests of above level sympathetic activation
Diagnostic Test: Testing of below level sympathetic activation
Diagnostic Test: Tests of sympathetic inhibition
Acute Spinal Cord Injury
Experimental group
Treatment:
Diagnostic Test: Tests of above level sympathetic activation
Diagnostic Test: Testing of below level sympathetic activation
Diagnostic Test: Tests of sympathetic inhibition

Trial contacts and locations

1

Loading...

Central trial contact

Zachary Pohlkamp

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems